Expert ID Field Answers A1 - Society of Toxicology · Expert ID Field Answers A1 Primary Interest:...
-
Upload
truongcong -
Category
Documents
-
view
241 -
download
0
Transcript of Expert ID Field Answers A1 - Society of Toxicology · Expert ID Field Answers A1 Primary Interest:...
Expert ID Field Answers
A1 Primary Interest: Biological Modeling
Additional Interest(s): Risk Assessment, Inhalation and Respiratory Toxicology
Employment: Academia
Prefers discussing: Research Discipline
Background:
Extensive experience in modeling of chemical kinetics, PBPK modeling, and
other mechanistic modeling, with applications to risk assessment
Meet time: Monday 1:00 pm; Tuesday 1:00 PM
A2 Primary Interest: Biological Modeling
Additional Interest(s): Mechanisms, Risk Assessment
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
Over 35 years of laboratory and human health risk assessment (RA) at EPA
and RTI. Systems biology focus. Four years experience with CWAE
Meet time: Tuesday 12:10
B1 Primary Interest: Biotechnology
Additional Interest(s): Regulatory and Safety Evaluation, Drug Discovery Toxicology;
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Research Scientist, Toxicology at a premier CRO. I serve as a Study Director
and is responsible for design, conduct, interpretation, and reporting of GLP
and non‐GLP preclinical toxicology studies of potential drug candidates in
rodents, canines, and non‐human primates. Recently earned PhD in
Pharmaceutical Sciences in December 2015. Graduate research focused on
characterizing the regulation of Fibroblast growth factor (Fgf) 21 and its
pharmacological/toxicological implications and a prior Bachelor’s
degree in Pharmacy from India. Reviewer for peer‐reviewed journals and is
actively involved in various groups/sections and programs within SOT.
Keen interest and passion to contribute and give back to the scientific
community as well as mentor upcoming graduate students.
Meet time: TBD
B2 Primary Interest: Biotechnology
Additional Interest(s): Mixtures, Cardiovascular Toxicology
Employment: Academia
Prefers discussing: Research Discipline
Background: Investigating transcriptional regulation of genes after xenobiotics
Meet time: Monday 10:30, Tuesday 10:30, Wednesday 10:30
C1 Primary Interest: Comparative & Veterinary Toxicology
Additional Interest(s): Not Specified
Employment: Academia
Prefers discussing: Research Discipline
Background:
Gestational bisphenol exposures in large mammals and in vitro exposures
in primary cells (metabolic and placental focus)
Meet time: Monday 12:30
C2 Primary Interest: Comparative & Veterinary Toxicology
Additional Interest(s): Drug Discovery Toxicology, Food Safety
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Currently work in Chemical and biological defense program management. I
support integration on studies across several programs to ensure
coordination of in vivo and in vitro studies toward medical countermeasure
development.
Meet time: Wednesday 5:00
D1 Primary Interest: Carcinogenesis
Additional Interest(s): Molecular Biology, Regulatory and Safety Evaluation
Employment: Academia
Prefers discussing: Research Discipline
Background:
Professor of Pharmacology and Toxicology, Michigan State University ‐
Research Interests: Epigenetic mechanisms underlying carcinogenesis,
safety assessment of non‐genotoxic rodent carcinogens ‐ Advisory Boards,
examples: Board of Scientific Councilors, National Toxicology Program;
Board of Scientific Councilors; National Institute of Environmental Health
Sciences, Education Sub‐Committee, European Societies of Toxicology
(EUROTOX) ‐ Society of Toxicology: President (1999‐2000), Merit Award
Recipient (2014)
Meet time: Tuesday 11:00
D2 Primary Interest: Carcinogenesis
Additional Interest(s): Drug Discovery Toxicology, Mechanisms
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Development of chemopreventive cancer gents; Lung cancer research;
Perinatal Carcinogenesis
Meet time: Monday 2:00, Tuesday 2:00, Wednesday 2:00
D3 Primary Interest: Carcinogenesis
Additional Interest(s): Drug Discovery Toxicology, Reproductive and Developmental Toxicology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
American board certified Toxicologist/ Pharmacologist working in the
pharmaceutical industry for about 20 years in the areas of drug discovery,
nonclinical drug development and nonclinical regulatory submissions. I am
experienced in designing, planning and monitoring, and data interpretation
of toxicology and pharmacology studies to support selection of preclinical
candidates, IND and NDA submissions and in writing nonclinical sections of
the IND and NDA regulatory documents. Studies I have conducted include
in vitro and in vivo ADME (absorption, distribution, metabolism and
excretion) and PK studies, general toxicology, genetic toxicology,
reproductive toxicology, juvenile toxicology, long‐term carcinogenicity and
safety pharmacology studies of several drugs candidates (small/large
molecules, peptides/protein) belonging to various therapeutics areas (GI
diseases, oncology, pain, inflammation, bone diseases). Worked with CROs
to conduct, complete and finalize GLP PK, ADME, safety pharmacology, and
toxicology studies for regulatory submissions. Worked effectively in
project teams/core teams as preclinical expert in setting timelines based
on project/company goals, prioritizing studies needed and completion of
work on time. Participated in due diligence activities of pharmaceuticals for
in‐licensing and research purposes to support Business Development and
Market Research. Managed, supervised and mentored junior staff.
Meet time: Monday 3:00, Tuesday 1:00, Wednesday 2:00
E1 Primary Interest: Dermal Toxicology
Additional Interest(s): In Vitro and Alternative Methods, Regulatory and Safety Evaluation
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Principal scientist at Dstl in the UK. Primarily interested in the
percutaneous penetration of toxic chemicals.
Meet time: Monday 11:00
F1 Primary Interest: Drug Discovery Toxicology
Additional Interest(s): Regulatory and Safety Evaluation, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: Computational chemistry, cheminformatics, drug discovery, software design
Meet time: Monday 9:15
F2 Primary Interest: Drug Discovery Toxicology
Additional Interest(s): Reproductive and Developmental Toxicology, Regulatory and Safety Evaluat
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Principal Scientist of Pfizer DSRD in Cambridge, MA. As a Drug Safety
Subject Matter Expert, DSTL (Drug Safety Team Lead), he represents drug
safety within project teams in multiple therapeutic areas and functions;
and provides nonclinical safety strategy in support of both GLP/non‐GLP
toxicity and efficacy studies in drug development and safety. Hank
received his M.S. in Toxicology from National Taiwan University in Taiwan
(1999) and his M.S. and Ph.D. in Pathology and Laboratory Medicine from
University of Rochester Medical School in Rochester, NY (2007) where he
initiated his professional interests in metabolic syndrome and reproductive
endocrinology. Currently he is in the D'Amore‐McKim School of Business
at Northeastern University to obtain the Master in Business
Administration, with specialty in HealthCare management.
Meet time: Monday 8:00, Tuesday 8:00, Wednesday 8:00
F3 Primary Interest: Drug Discovery Toxicology
Additional Interest(s): Biotechnology, Regulatory and Safety Evaluation
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Works with a non profit Contract Research Organization called Battelle.
Joined Battelle as a Principal Reserarch Scinetist and Study Diretcor in Sept
20015 immediately after my PhD. I have a background of Veterinary
Science and Veterinary Pathology. I would be happy to discuss on
questions on any topic ranging from life in non profit CRO, how to prepare
for a job during PhD, keys of job search, appearing for personal interviews
etc.
Meet time: TBD
F4 Primary Interest: Drug Discovery Toxicology
Additional Interest(s): Mechanisms, Regulatory and Safety Evaluation
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I am a senior director and currently lead the nonclinical toxicology group at
Genentech (~50 staff) who perform drug discovery lead optimization,
investigative and regulatory functions. I am also a board certified
veterinary pathologist. I have been in the industry for 20 years.
Meet time: Monday 10:00, Tuesday 1:00
F5 Primary Interest: Drug Discovery Toxicology
Additional Interest(s): Mechanisms
Employment: Academia
Prefers discussing: Research Discipline
Background: Decades in academia; directs a graduate program; interest in liver toxicology
Meet time: Monday 2:00, Tuesday 2:00
F7 Primary Interest: Drug Discovery Toxicology
Additional Interest(s): Biotechnology, Regulatory and Safety Evaluation
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
20 years in drug development toxicology, 30+ years in toxicology overall
(including CROs)
Meet time: Monday 2:00, Tuesday 10:00
G1 Primary Interest: Ethical, Legal and Social Issues
Additional Interest(s): Mixtures, Risk Assessment
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background: I have 40 years in the field of chemical risk assessment. My current research
Meet time: Wednesday 11:30
H1 Primary Interest: Food Safety
Additional Interest(s): Regulatory and Safety Evaluation, Risk Assessment
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
I have spent over 30 years as a corporate toxicologist working in the
chemicals, pesticides, excipeints and food additive safety issues and the
last 9 years as a consultant. My background is toxicology for regulatory
decision making, risk assessment and food safety. I am a DABT and Fellow
of ATS.
Meet time: Tuesday 12:15, Wednesday 12:15
H2 Primary Interest: Food Safety
Additional Interest(s): Regulatory and Safety Evaluation, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I have been working in the consumer packaged goods industry supporting
both household chemicals as well as food safety.
Meet time: Monday 11:00, Tuesday 11:00, Wednesday 11:00
H3 Primary Interest: Food Safety
Additional Interest(s): Dermal Toxicology, Risk Assessment
Employment: Acadmia
Prefers discussing: Research Discipline
Background:
Extensive experience in toxicology in industry/academy/consulting for
government and industry. Knowledgeable about publishing [editor in chief
of several journals and Hayes' Principles and Methods of Toxicology
Meet time: Tuesday 2:00, Wednesday 2:00
I1 Primary Interest: Immunotoxicology
Additional Interest(s): Reproductive and Developmental Toxicology, Neurotoxicology
Employment: Academia
Prefers discussing: Research Discipline
Background:
Basic research scientist in academia who completed a federal government
postdoc and who mainly studies PFASs.
Meet time: Tuesday 2:00, Wednesday 10:00
I2 Primary Interest: Immunotoxicology
Additional Interest(s): In Vitro and Alternative Methods, Neurotoxicology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Industry investigative tox. Toxin mechanisms. Immunotoxicity and
protection. Vaccines study director.
Meet time: Monday 11:00, Tuesday 11:00, Wednesday 11:00
I3 Primary Interest: Immunotoxicology
Additional Interest(s): Biotechnology, Regulatory and Safety Evaluation
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
>20 years in the biopharmaceutical industry with expertise in biologics
drug development and immunotoxicology.
Meet time: Tuesday 10:00
I4 Primary Interest: Immunotoxicology
Additional Interest(s): Molecular Biology, Biotechnology
Employment: Academia
Prefers discussing: Research Discipline
Background:
Columbia. My area of research includes Mol Immunology, Epigenetics, and
Immmunotoxucity.
Meet time: Monday 3:30
I6 Primary Interest: Immunotoxicology
Additional Interest(s): Mechanisms, Neurotoxicology
Employment: Academia
Prefers discussing: Research Discipline
Background:
I am a Professor of Pharmacology and Cancer Biology at Duke University
Medical Center and of Neurobiology. The focus of the proposed study is
the development of serum biomarker for neural injury in an animal model
that we previously developed, for the Gulf War Veterans’ illnesses. This
includes diagnostic studies of long term consequences of nervous system
injury from various causes. I obtained his Ph.D. from the University of
California at Berkeley. I am a Certified Toxicologist by both the American
Board of Toxicology and the Academy of Toxicological Sciences. I edited
two books “Neurotoxicology†and Mammalian Toxicology.
Meet time: Monday 10:00 pm
J1 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Drug Discovery Toxicology, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: Associate Research Director, Syngene International Ltd, e.mail: Sonali.Das@
Meet time: Wednesday 12:30
J2 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Stem Cells, Cardiovascular Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Principal Investigator at the National Center for Toxicological Research, US
FDA, where she serves as the PI of three NCTR protocols, one of which is
supported by the FDA Office of Women’s Health and two are supported
by the FDA Center for Drug Evaluation and Research (CDER). Her current
research interests include studying sex differences in drug‐induced QT
prolongation and Torsade de Pointes, developing early biomarkers for
radiation‐induced heart disease, and using iPSC‐hCMs model for drug‐
induced cardiotoxicity detection. She received her doctorate in clinical
medicine from North China Coal Medical College in 1993 and was a
postdoctoral fellow at the Montreal Heart Institute from 2000‐2004.
Before joining the FDA, Dr. Pang was a faculty member of the Department
of Pharmacology & Toxicology at the University of Arkansas for Medical
Sciences, where she served as the PI of a NHLBI‐funded RO1 project. She is
author/co‐author of 16 peer‐reviewed articles and her work has been cited
for more than 900 times. Dr. Pang has been a member of the SOT since
2015 and is a member of Cardiac Safety Research Consortium since 2014.
Meet time: Wednesday 9:15
J3 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Inhalation and Respiratory Toxicology, Medical Device
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
PhD in Cellular and Molecular Biology; Current President of SOT’s In
Vitro and Alternative Methods Specialty Section.
Meet time: Monday 7:00, Thursday 7:00
J4 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Mechanisms, Carcinogenesis
Employment: Academia
Prefers discussing: Research Discipline
Background:
I have been a professor of toxicology for nearly 40 years at a major
research university (Univ. Washington). I currently serve as Dean and Vice
Provost of the Graduate School for all of UW. I have been involved with
SOT my entire career, and served as President in 2001. I Received the SOT
Achievement Award, and the Public Communications Award, and was
Elected to the National Academy of Medicine in 2011.
Meet time: Monday 10:00, Tuesday 10:00
J5 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Risk Assessment, Food Safety
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
I am a Toxicologist at a contract research organization called Integrated
Laboratory Systems, Inc. where we support the NTP Interagency Center for
the Evaluation of Alternative Toxicological Methods (NICEATM). My work
focuses on promoting the development, validation, acceptance, and use of
alternative and revised testing methods. I have a PhD in Biochemistry and
Toxicology from Michigan State University, after which I did a government
postdoc the US EPA’s National Center for Computational Toxicology
working with the ToxCast high‐throughput screening program.
Meet time: Tuesday 4:30
J6 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Mechanisms, Clinical and Translational Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
I am with FDA NCTR and I have a focused research area: mechanisms and
biomarkers for DILI. I have more than 15 years’ experience in
culture of primary hepatocytes from multiple species with a
mechanistic focus on drug induced mitochondrial damages and
metabolism‐mediated hepatocyte injury. For biomarker studies, I use
both animal models and human clinical samples to explore novel
translational DILI biomarkers, focusing on circulating microRNAs in the
urine and blood.
Meet time: Monday 2:00
J7 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Drug Discovery Toxicology, Mechanisms
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
26 years experience in cytotoxicity assay development used for high
throughput screening.
Meet time: Monday 4:00
J8 Primary Interest: In Vitro and Alternative Methods
Additional Interest(s): Regulatory and Safety Evaluation, Dermal Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
I have collabolations with a few universities and assit the studesnts for
research field. On the other hand, I teached the in vitro toxicology or
safety assessment of cosmetic in severeal univesities as a visitig professor.
Meet time: Monday 1:00, ,Tuesday 1:00
K1 Primary Interest: Inhalation and Respiratory Toxicology
Additional Interest(s): Regulatory and Safety Evaluation, Biotechnology
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
Worked for Gov't (EPA), Industry (Genetech, Bayer) and currently an
independent consultant.
Meet time: Monday 12:00, Tuesday 12:00, Wednesday 12:00
K2 Primary Interest: Inhalation and Respiratory Toxicology
Additional Interest(s): Clinical and Translational Toxicology, Occupational Health
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Discovering health effects of air pollution exposures using in vitro cell, in
vivo rodent and human exposures.
Meet time: Monday 10:00, Tuesday 10:00, Wednesday 10:00
K4 Primary Interest: Inhalation and Respiratory Toxicology
Additional Interest(s): Regulatory and Safety Evaluation, Occupational Health
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background: I am a consultant with history performing inhalation animal safety studies.
Meet time: Wednesday 2:00
K5 Primary Interest: Inhalation and Respiratory Toxicology
Additional Interest(s): Mechanisms, Molecular Biology
Employment: Academia
Prefers discussing: Research Discipline
Background:
Inhalation biology ‐ exposure biology to human and rodents in relation to
toxicology in the pathogenesis of chronic lung diseases and oral diseases.
Meet time: Monday 1:00, Tuesday 1:00, Wednesday 1:00
L1 Primary Interest: Mechanisms
Additional Interest(s): Metals, Neurotoxicology
Employment: Other
Prefers discussing: Research Discipline
Background:
My background is multivaried and my pathway was NOT a straight line.
Toxicology is my 2nd career, proving it's never too late for a change.
Meet time: Tuesday 10:30, Wednesday 2:00
L2 Primary Interest: Mechanisms
Additional Interest(s): In Vitro and Alternative Methods, Nanotoxicology
Employment: Academia
Prefers discussing: Research Discipline
Background:
Molecular Toxicologist ‐ use functional approaches to understand
mechanisms of toxicity.
Meet time: Monday 12:00, Tuesday 12:00, Wednesday 12:00, Thursday 12:00
L3 Primary Interest: Mechanisms
Additional Interest(s): Nanotoxicology, Toxicologic Pathology & Exploratory Pathology
Employment: Academia
Prefers discussing: Research Discipline
Background:
I am a career academic who has worked in both high‐profile and low‐
profile research institutions; knows how to balance teaching & research; I
can share my experience with anyone interested in learning how to land in
well‐paying academic job (TT/ non TT or similar). My accomplishments can
be found at the URL: sidhartharay.com. I have mentees throughout the US.
Meet time: Monday 2:00, ,Tuesday 2:00
L4 Primary Interest: Mechanisms
Additional Interest(s): Immunotoxicology, Food Safety
Employment: Academia
Prefers discussing: Research Discipline
Background: Had been working in toxicology for the last thirty five year.
Meet time: Tuesday 11:00, Wednesday 11:00
L5 Primary Interest: Mechanisms
Additional Interest(s): Carcinogenesis, Stem Cells
Employment: Academia
Prefers discussing: Research Discipline
Background:
I am an academic scientist with broad research interests in mechanisms of
liver injury, regeneration, cancer and use of bioinformatics to solve
mechanistic problems. I am originally from India, did my PhD here in the
US and now have my own laboratory.
Meet time: TBD
M1 Primary Interest: Medical Device
Additional Interest(s): Risk Assessment, Clinical and Translational Toxicology
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
Medical device Toxicologist with extensive analytical chemistry and
pharmacology background.
Meet time: Monday 12:00
N1 Primary Interest: Metals
Additional Interest(s): Carcinogenesis, Molecular Biology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background: Understanding the role of metal deregulation in cancer, esp with analysis me
Meet time: Monday 8:30, Tuesday 8:30, Wednesday 8:30, Thursday 8:30
O1 Primary Interest: Mixtures
Additional Interest(s): Metals, Inhalation and Respiratory
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background: Grant Program Administrator at NIEHS and the NIEHS Superfund Research P
Meet time: Monday 9:00, Tuesday 9:00
P1 Primary Interest: Molecular Biology
Additional Interest(s): Mechanisms, In Vitro and Alternative Methods
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background: Epigenetics, in vitro models, and clinical/translational toxicology.
Meet time: Monday 4:30, Tuesday 4:30
Q1 Primary Interest: Nanotoxicology
Additional Interest(s): In Vitro and Alternative Method
Employment: NGO
Prefers discussing: Employment Sector and Research Discipline
Background:
A nanotoxicology specialist for the PETA International Science Consortium
Ltd. She received her Ph.D. in Biomedical Sciences from Wright State
University with Nanotoxicology as the main area of focus. As the
Nanotoxicology Specialist at the PETA International Science Consortium
Ltd., She researches and promotes human‐relevant non‐animal methods to
assess nanotoxicity. She participates on the International Organization for
Standardization (ISO) Technical Committee on nanotechnology and the
Organization for Economic Co‐operation and Development Working Party
for Manufactured Nanomaterials (OECD WPMN) to ensure the best non‐
animal methods are included in international standards and guidelines for
nanomaterial testing.
Meet time: Monday 12:00, Tuesday 12:00, Wednesday 12:00
Q2 Primary Interest: Nanotoxicology
Additional Interest(s): In Vitro and Alternative Method, Inhalation and Respiratory
Employment: Academia
Prefers discussing: Research Discipline
Background: Development of 3D in vitro models.
Meet time: Monday 12:00
Q3 Primary Interest: Nanotoxicology
Additional Interest(s): Inhalation and Respiratory, Immunotoxicology
Employment: Academia
Prefers discussing: Research Discipline
Background:
Professor and Director of the Toxicology Graduate Program at NC State
University. He research interests are in nanotoxicology, lung biology and
immunology. He has broad career experience in toxicology from working in
government, non‐profit, industry and academia.
Meet time: Monday 9:00, Tuesday 9:00, Wednesday 9:00
Q4 Primary Interest: Nanotoxicology
Additional Interest(s): Carcinogenesis, In Vitro and Alternative Methods
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
My primary research focus is using both in vitro and in vivo methods to
assess pulmonary toxicity risk of engineered nanomaterials, including
carbon nanotubes, metal oxides, and nanoclays. Within these studies, my
group evaluates potential for chronic diseases including carcinogenesis and
fibrosis, and their underlying mechanisms. I have a broad environmental
toxicology background including pulmonary toxicology, lung cancer, and
aquatic ecotoxicology.
Meet time: Wednesday 1:00
R1 Primary Interest: Neurotoxicology
Additional Interest(s): Stem Cells, Metals
Employment: Academia
Prefers discussing: Research Discipline
Background:
My lab studies gene x toxicant interactions (especially metals) in the
context of neurological disease.
Meet time: Tuesday 9:00
R2 Primary Interest: Neurotoxicology
Additional Interest(s): Drug Discovery Toxicology, Clinical and Translational Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
My research explores the mechanisms by which nerve agents affect the
central nervous system.
Meet time: Monday 1:00, Tuesday 1:00, Wednesday 1:00
R3 Primary Interest: Neurotoxicology
Additional Interest(s): Not Specified
Employment: Academia
Prefers discussing: Research Discipline
Background:
Recently tenured neurotoxicologist who studies environmentally‐induced
neurodegeneration.
Meet time: Wednesday 9:00
R4 Primary Interest: Neurotoxicology
Additional Interest(s): Clinical and Translational Toxicology, Cardiovascular Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Pharmacologist/toxicologist with emphasis on CNS; translational tox;
animal models; developmental neurotox of pediatric anesthetics.
Meet time: Monday 8:00
R5 Primary Interest: Neurotoxicology
Additional Interest(s): Reproductive and Developmental Toxicology, Stem Cells
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Director of the National Center for Toxicological Research/FDA. Research
interests include developmental neurotoxicology and biomarker
development. Past president of SOT, ATS and Teratology.
Meet time: Monday 2:00, Tuesday 2:00, Thursday 9:00
R6 Primary Interest: Neurotoxicology
Additional Interest(s): Mechanisms, Metals
Employment: Academia
Prefers discussing: Research Discipline
Background: Undergraduate educator who also has an active, funded research lab.
Meet time: TBD
S1 Primary Interest: Occupational Health
Additional Interest(s): Regulatory and Safety Evaluation, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: Board‐certified toxicologist versed in risk assessment. Experienced in produc
Meet time: Monday 4:15
T1 Primary Interest: Ocular Toxicology
Additional Interest(s): Not Specified
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: I have been involved in nonclinical ocualr toxicology for over 15 years. In ad
Meet time: Wednesday 10:00, Thursday 10:00
U1 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Dermal Toxicoloy; Carcinogenesis
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
I have spent more than 40 years in the CRO industry and am familiar with
regulatory and safety evaluation issues in a wide variety of areas. I have
presented nationally and internationally on Study Director issues.
Meet time: Monday 10:00
U2 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment,
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I have expertise in both traditional and structure‐activity‐relationship
based read‐across hazard and risk assessment of chemicals, as well as in
global chemical registration regulations such as EU REACH.
Meet time: Monday 11:30, Tuesday 1:00, Wednesday 12:30
U3 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): In Vitro and Alternative Methods, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: ERT working in biotech industry as a Product Stewarsdship/Regulatory Speci
Meet time: Monday 3:00, Tuesday 2:00, Wednesday 9:00
U4 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Clinical and Translational Toxicology, Food Safety
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Hands‐on experience with management of both pre‐clinical and clinical
toxicologic research, submission of both food additive petitions and GRAS
Meet time: Monday 1:30, Tuesday 1:30, Wednesday 4:40
U5 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment, Reproductive and Developmental Toxicology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Use of toxicological sciences to support safe use of petrochemical
products. Design, conduct and evaluation of toxicology studies.
Communication of results to internal and external audiences.
Meet time: Tuesday 12:00, Wednesday 12:00
U6 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment, Inhalation and Respiratory Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Received my PhD in molecular carcinogenesis, working as a toxicologist for
a Texas environmental regulator.
Meet time: Wednesday 2:00
U7 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
Responsible for providing technical support on the science and regulation
of personal care products.
Meet time: Monday 1:30, Tuesday 1:30
U8 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: Regulatory Toxicology; Product Safety; Product Stewardship.
Meet time: Tuesday 11:00
U9 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background: Pesticide toxicology/risk assessment & registration with US EPA
Meet time: Monday 9:15, Tuesday 9:15, Wednesday 9:15
U10 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Clinical and Translational Toxicology, Drug Discovery Toxicology
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
Board certified toxicologist with >25 years of research experience in
toxicology and over 24 years experience in the pharmaceutical industry
with extensive experience in the development of new molecular entities,
medical devices, reformulations of marketed products and global product
registration and support.
Meet time: Monday 10:30
U11 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Cardiovascular Toxicology, Molecullar Biology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Major in Pharmacology & Toxicology; Working in systems biology area
including transcriptomics, proteomics, metabolomics and epigenetics;
Mainly conduct bioinformatic analysis using SAS, R, JMP and Pathway
analysis.
Meet time: Monday 9:15, Tuesday 9:15, Wednesday 9:15
U12 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment, Dermal Toxicology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Industrial toxicologist with over 15 years of experience in large Pharma and
Vaccines.
Meet time: Monday 10:00, Tuesday 10:00, Wednesday 9:00
U13 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Clinical and Translational Toxicology, Drug Discovery Toxicology
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
35+ years' experience at a large non‐profit CRO doing drug development
across many disease areas.
Meet time: Monday 1:30
U14 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): In Vitro and Alternative Methods, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
Regulatory scientist in safety assessment of toxicological data. Review and
provide assessment on risk assessment, modeling, in‐vitro and alternative
testing, coordinate testing startegy with CROs, interphase with EPA and
marketing division, prepare dossiers for regulatory submissions.
Meet time: Monday 3:00, Tuesday 2:00, Wednesday 3:00
U15 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Risk Assessment, Mixtures
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
I'm a Senior Toxicologist at an Environmental Health consulting firm
(Gradient) who's primary areas of expertise include mode of action, risk
assessment, chemical hazard assessment, and toxicity criteria
development.
Meet time: Monday 2:00, Tuesday 9:30, Wednesday 9:30
U16 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Reproductive and Developmental Toxicology, Drug Discovery Toxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Completed undergraduate work in marine biology in Colombia, a MS in
environmental toxicology and a PhD in toxicology from the University of
Maryland.Currently a Pharmacology and Toxicology reviewer for oncology
and benign hematology drug products in the US FDA‐CDER. He has worked
in early discovery, lead optimization and nonclinical development of small
molecule pharmaceuticals and biologics. As a study director, he conducted
general toxicology, carcinogenicity and Developmental and Reproductive
Toxicology nonclinical studies and has more than 20 years of experience in
GLP. He conducts peer review of articles for the International Journal of
Toxicology.
Meet time: Tuesday 11:30
U17 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Food Safety, Risk Assessment
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background: Toxicologist in the Food Industry with prior experience in contract research
Meet time: Monday 9:00
U18 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Immunotoxicology, Drug Discovery Toxicology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
25+ years of drug development experience with major pharma in CV,
metabolic diseases, oncology, immunology and inflammation.
Meet time: Tuesday 7:30
U19 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Drug Discovery Toxicology, Carcinogenesis
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I am a senior project toxicologist at Bristol‐Myers Squibb working on a
variety of drug development programs including small molecules, biologics
and antibody drug conjugates.
Meet time: Tuesday 7:30
U20 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Dermal Toxicology, Stem Cells
Employment: Other
Prefers discussing: Employment Sector and Research Discipline
Background:
Director, Photobiology and Cellular Therapeutic Safety. 28 years of
pharma and CRO experience.
Meet time: Monday 9:00, Tuesday 11:00, Wednesday 2:00, Thursday 9:00
U21 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Drug Discovery Toxicology, In Vitro and Alternative Methods
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
35 years pharmaceutical drug discovery and development expertise with
major pharma companies.
Meet time: Monday 7:30, Tuesday 7:30, Wednesday 7:30
U22 Primary Interest: Regulatory and Safety Evaluation
Additional Interest(s): Not Specified
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
I am an independent toxicology consultant who works with companies in
the pharmaceutical, food and chemical industries to assist with their
regulatory toxicology needs.
Meet time: Tuesday 9:15
V2 Primary Interest: Reproductive and Developmental Toxicology
Additional Interest(s): Molecular Biology, Mechanisms
Employment: Goverrnment
Prefers discussing: Employment Sector and Research Discipline
Background:
Toxicity assessment of products of interest to the FDA. Characterization of
novel biomarkers of toxicity.
Meet time: Tuesday 10:30
V3 Primary Interest: Reproductive and Developmental Toxicology
Additional Interest(s): Regulatory and Safety Evaluation,
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
I have been working in the commercial sector for over 40 years and as a
consultant 35. My focus is regulatory developmental and reproductive
toxicology.
Meet time: Monday 10:00, Tuesday 10:00, Wednesday 10:00
V4 Primary Interest: Reproductive and Developmental Toxicology
Additional Interest(s): Regulatory and Safety Evaluation, Neurotoxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
I am an FDA expert in infant toxicology and lifestage‐specific safety
assessment. I have a PhD in toxicology with a specialization in
developmental neurotoxicology and certification in risk sciences and public
policy.
Meet time: Monday 10:00, Tuesday 2:00
V5 Primary Interest: Reproductive and Developmental Toxicology
Additional Interest(s): Mechanisms, In Vitro and Alternative Methods
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
I recieved my PhD in toxicology form University of Michigan. I also have an
MPH and Biomedical Engineering degress from Universtiy of Minnesota. I
have worked in risk assessment for a state health department. I also have
extensive research experience. I am currently a postdoctoral fellow at the
USEPA.
Meet time: Monday 12:00, Tuesday 12:00, Wednesday 12:00, Thursday 12:00
V6 Primary Interest: Reproductive and Developmental Toxicology
Additional Interest(s): Molecular Biology, Neurotoxicology
Employment: Academia
Prefers discussing: Research Discipline
Background:
My expertise in the area of developmental toxicology using Japanese
medaka fish as my experimental model. We have used medaka embryos
for epigentic assessment of the developmental disorder induced by
ethanol and natural products.
Meet time: Monday 12:30, Tuesday 12:30, Wednesday 12:30
W1 Primary Interest: Risk Assessment
Additional Interest(s): Carcinogenesis, In Vitro and Alternative Methods
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
Training in carcinogenesis and molecular biology; currently working on
biomonitoring and HTS methods.
Meet time: Wednesday 2:30
W2 Primary Interest: Risk Assessment
Additional Interest(s): Regulatory and Safety Evaluation, In Vitro and Alternative Methods
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background:
My background is on the risk assessment of industrial chemicals and
pesticides. I also actively work on projects assesing the applicability of
alternative methods to animal testing for regulatory purposes.
Meet time: Monday 12:30
W3 Primary Interest: Risk Assessment
Additional Interest(s): Regulatory and Safety Evaluation
Employment: NGO
Prefers discussing: Research Discipline
Background:
Human health risk assessment of environmental chemicals; consumer
product safety.
Meet time: Wednesday 3:00
W4 Primary Interest: Risk Assessment
Additional Interest(s): Mixtures, Ethical, Legal, and Social Issues
Employment: Academia
Prefers discussing: Research Discipline
Background:
My focus is on evaluating health effects of chemicals, determining
exposure limits (e.g., RfDs), and improving methods for doing so, including
dosimetry and use of AOPs. I have worked in academic, consulting, and
nonprofit environments.
Meet time: TBD
W5 Primary Interest: Risk Assessment
Additional Interest(s): Metals, Epidemiology
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
Diverse background starting with academia to government to consulting,
experience in practical application of toxicology.
Meet time: Wednesday 7:00, Thursday 7:00
W6 Primary Interest: Risk Assessment
Additional Interest(s): Metals, Epidemiology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I am currently the Section Head for the Epidemiology, Health Surveillance,
and Quality Assurance (QA) Teams at ExxonMobil Biomedical Sciences, Inc.
(EMBSI). I am responsible for coordinating epidemiology and QA programs
for ExxonMobil global business units and external collaborations. Previous
to my current role, I was Section Head for Toxicology at EMBSI, where I
coordinated all internal toxicology programs. I am actively involved in the
advancement of emerging and progressive risk assessment methods. I
received my PhD in Toxicology from the University of Rochester in 2004 in
the lab of Dr. Thomas A. Gasiewicz.
Meet time: Monday 4:00, Tuesday 4:00, Wednesday 4:00, Thursday 8:00
W7 Primary Interest: Risk Assessment
Additional Interest(s): Ethical, Legal, and Social Issues, In Vitro and Alternative Methods
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
Currently a consultant; expertise/background is in PBPK modeling and risk
assessment.
Meet time: Tuesday 3:00, Wednesday 3:00
W8 Primary Interest: Risk Assessment
Additional Interest(s): Medical Device, Occupational Health
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I am a regulatory tioxicologist with major pharma and write risk
assessment to support combination products, extraneous matter, etc. as
well as set occupational expousre limits for staff for APIs.
Meet time: Tuesday 11:45
W9 Primary Interest: Risk Assessment
Additional Interest(s): Regulatory and Safety Evaluation, Ethical, Legal, and Social Issues
Employment: Consultant
Prefers discussing: Employment Sector and Research Discipline
Background:
I am a pharmacologist, toxicologist, human health risk assessor and patent
agent. I work as a consultant in my own company.
Meet time: Monday 4:00, Tuesday 9:00, Wednesday 9:00
W10 Primary Interest: Risk Assessment
Additional Interest(s): Comparative & Veterinary Toxicology, Immunotoxicology
Employment: Government
Prefers discussing: Employment Sector and Research Discipline
Background: Use various and alternal lab animal models to develop safe levels of exposur
Meet time: Tuesday 1:00
X1 Primary Interest: Toxicologic Pathology & Exploratory Pathology
Additional Interest(s): Immunotoxicology, Biotechnology
Employment: Industry
Prefers discussing: Employment Sector and Research Discipline
Background:
I am trained and experienced in toxicology (general) and veterinary
pathology. I have worked in academic, contract research, and
pharmaceutical industry settings. Outside of toxicology, I workked as a
medical anthropologist and enjoy learning about cultures, cultural
transitions and cross‐cultural engagements.
Meet time: Wednesday 12:00
@syngeneintl.com. I have joined Syngene International, one of the leading CROs in Biotech, in August 2016, as an
ct safety and occupational health in both the consumer goods and pharmaceutical industries.
dition, I have conducted general toxicology studies in support of INDs.
n Associate Research Director and leading the team Heptox.Prior to joining Syngene I was at Strand Life Sciences
s Pvt Ltd, a bioinformatics company, over a period of 10 years (2006 – present). At Strand I was leading the pr
oject involved in prediction of drug induced liver injury. The DILI prediction platform Heptox is a Systems Biology
y approach to develop a platform to predict Drug Induced Liver Injury (DILI). I was involved from the very beginn
ning of conceiving the idea of this R & D endeavor, developing multiple modules and integrating them into one c
common kinetics‐based model to predict DILI. Heptox team at Strand obtained a nation‐wide competitive fundi
ng ‐ a DBT‐funded programme BIPP, in 2010‐2011 for validation of the DILI prediction platform where I contribu